Therapeutic Options in Locally Advanced Thymoma
Thymoma is the most common tumor of the anterior mediastinum. Most thymomas will present as a well encapsulated tumor which can be resected for cure in 80–90% of patients. Many of these patients have paraneoplastic syndromes such as myasthenia gravis, hypogammaglobulinemia, or pure red cell aplasia, which others may have symptom of local disease such as chest pain or superior vena caval obstruction. About one-third of patients present with asymptomatic mass on chest radiograph which ultimately prompts further evaluation.1
KeywordsClin Oncol Eastern Cooperative Oncology Group Objective Response Rate Thymic Carcinoma Combine Modality Therapy
Unable to display preview. Download preview PDF.
- 1.Loehrer PJ: Thymomas. Current experience and future directions in therapy. Drugs 45(4):477-487, 1993.Google Scholar
- 15.Harper PG, Highley M, Rankin E, et al: Ifosfamide monotherapy demonstrates high activity in malignant thymoma (abstract). Proc Am Soc Clin Oncol 10:300, 1991.Google Scholar
- 17.Gordon MS, Battiato LA, Gonin R, et al: A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma. J Immunother 1996 (in press).Google Scholar
- 19.Loehrer PJ, Kim K, Chen M, et al: Phase II trial of cisplatin (P), adriamycin (A), cyclophosphamide (C) plus radiotherapy in limited stage unresectable thymoma (abstract 1375). Proc Am Soc Clin Oncol 14:433, 1995.Google Scholar